MedTrace Logo

Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer

NCT00921193 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-03-30

No results posted yet for this study

Summary

The study aims to evaluate the safety and performance of the RTPS in patients with localized prostate cancer.The RTPS is an investigational device and requires permanent implantation of a small radioactive fiducial, called the Blip, in the prostate.

Conditions

Interventions

DEVICE

Radiation Therapy Positioning System (RTPS)

Sponsors & Collaborators

  • Navotek Medical, Ltd.

    lead INDUSTRY

Principal Investigators

  • Philip MP Poortmans, MD, PhD · Dr. Bernard Verbeeten Instituut

  • Willy JM de Kruijf, PhD · Dr. Bernard Verbeeten Instituut

  • Karin Haustermans, MD · Leuvens Kankerinstituut

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921193 on ClinicalTrials.gov